5
7

Protect Patients from Costly Care Act

9/30/2025, 11:44 PM

Summary of Bill HR 5094

This bill, designated as H.R. 5094 in the 119th Congress, aims to repeal alterations related to Medicaid cost sharing rules and the exemption of orphan drugs within the Medicare Drug Price Negotiation Program. Introduced on September 2, 2025, the bill focuses on addressing these specific components within the broader healthcare framework.

Current Status of Bill HR 5094

Bill HR 5094 is currently in the status of Bill Introduced since September 2, 2025. Bill HR 5094 was introduced during Congress 119 and was introduced to the House on September 2, 2025.  Bill HR 5094's most recent activity was Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. as of September 2, 2025

Bipartisan Support of Bill HR 5094

Total Number of Sponsors
1
Democrat Sponsors
1
Republican Sponsors
0
Unaffiliated Sponsors
0
Total Number of Cosponsors
8
Democrat Cosponsors
8
Republican Cosponsors
0
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill HR 5094

Primary Policy Focus

Health

Alternate Title(s) of Bill HR 5094

To repeal changes to Medicaid cost sharing requirements and the exclusion for orphan drugs under the Medicare Drug Price Negotiation Program.
To repeal changes to Medicaid cost sharing requirements and the exclusion for orphan drugs under the Medicare Drug Price Negotiation Program.

Comments